Register for our free email digests:
Latest From Neos Therapeutics Inc.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2017.
Public biopharma offerings gained momentum, including four IPOs during the last week of June, as US investors looked kindly on the sector ahead of July 4 celebrations. Also, VC investment continued unabated as Atlas Venture closed a new $350m fund.
The latest drug development news and US FDA highlights from our Performance Tracker.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Diagnostic Imaging Equipment & Supplies
- Monitoring Equipment & Devices
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Middle East
- Parent & Subsidiaries
- BioView Ltd.
- Senior Management
Alan Schwebel , PhD, Pres. & CEO
Marina Wolfson, Dir., Fin.
- Contact Info
3 Pakris St. Rehovot
P.O. Box 4051 Nes Ziona , 70400
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.